Examen has received further support from Invest Northern Ireland under the European Union’s Investment for Growth and Jobs Programme. The project will be implemented over the next two years, performing research and development activities aimed at developing new products aligned with market demand to expand the customer base outside Northern Ireland.

Sheena Lewis, CEO of Examen said: “Our novel sperm DNA tests for infertility and miscarriage will allow healthcare professionals to provide a more accurate diagnosis and enable them to guide couples to the fastest route for them to become families.

“Examen has received a range of support from Invest NI over the ten years since our business opened allowing us to grow and build our product portfolio; create new jobs; and upskill our experienced workforce. This partnership approach has allowed us to scale quickly and increase our competitiveness. Over the coming months we will focus on accelerating this growth even further by expanding sales outside Northern Ireland.”